Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives
Viruses · 07.07.2026 · 18 (7) · 750
DOI: 10.3390/v18070750 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 07.07.2026. Verfasst von Shiqiang Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Food Laboratory of Zhongyuan, College of Food Science and Technology, Henan University of Technology, Zhengzhou 450001, China. Hauptthemen laut MEDLINE: Feline Panleukopenia, Feline Panleukopenia Virus, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 Key Research and Development Program of Henan Province, the Foundation of Key Technology Research Project of Henan Province.
Abstract (Originalsprache)
Feline panleukopenia is a highly contagious and often fatal disease in cats caused by the feline panleukopenia virus (FPV), a member of the Parvoviridae family. Despite the widespread use of vaccination, FPV remains a significant threat to both domestic and wild felid populations worldwide, particularly in young or unvaccinated animals. Effective vaccination strategies are therefore essential for controlling the disease and reducing mortality. Current vaccines, including modified live and inactivated vaccines, have demonstrated substantial efficacy in inducing protective immunity; however, several challenges remain, such as maternal antibody interference, vaccine failure, and safety concerns in certain animal populations. Recent advances in vaccine technology have spurred the development of next-generation FPV vaccines, including recombinant vectors, DNA vaccines, virus-like particle (VLP) vaccines, and novel delivery platforms. Among these, probiotic-based vaccine vectors have garnered growing interest due to their favorable safety profiles, mucosal immunogenicity, and suitability for oral administration. These systems may provide innovative approaches for inducing both systemic and mucosal immune responses against FPV. This review summarizes the current understanding of the immunological mechanisms underlying protection against FPV infection and discusses the progress made in FPV vaccine development. Furthermore, it highlights the major challenges associated with current vaccination strategies and explores emerging vaccine platforms, including probiotic vector-based vaccines, as promising tools for future disease control. Improved vaccine design and optimized immunization strategies will be crucial for enhancing the prevention of feline panleukopenia in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Food Laboratory of Zhongyuan, College of Food Science and Technology, Henan University of Technology, Zhengzhou 450001, China.
- Department of Nutrition and Health, China Agricultural University, Beijing 100083, China.
ORCID-Profile: Shiqiang Zhu, Weiwei Wang, Huakai Wang, Liang Zhao
Förderung
- 2024 Key Research and Development Program of Henan Province
- the Foundation of Key Technology Research Project of Henan Province
Zitieren
APA
Zhu, S., Wang, W., Wang, H., Zhang, Y., Zhao, L., & Xiong, W. (2026). Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives. Viruses, 18(7), 750. https://doi.org/10.3390/v18070750
Vancouver
Zhu S, Wang W, Wang H, Zhang Y, Zhao L, Xiong W. Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives. Viruses. 2026;18(7):750. doi:10.3390/v18070750
BibTeX
@article{Zhu2026,
author = {Zhu, Shiqiang and Wang, Weiwei and Wang, Huakai and Zhang, Yuqiang and Zhao, Liang and Xiong, Wei},
title = {Advances in Feline Panleukopenia Virus Vaccines: Immunological Mechanisms, Current Challenges, and Future Perspectives},
journal = {Viruses},
year = {2026},
volume = {18},
number = {7},
pages = {750},
doi = {10.3390/v18070750}
}
EUVIMED